Results
1 -
10 of
53
(Click
here to explore results)
- New Frontiers in Chemical Biology: Enabling Drug Discovery, Chapter 7 Antibody–Drug Conjugates in Oncology. Philip R. Hamann, Russell G. Dushin
, 2011
, Pages 224-257
- Cytotoxic Payloads for Antibody–Drug Conjugates, CHAPTER 6 Colchicine-, Vinblastine-, Taxol- and Eribulin-based Payloads for Antibody–Drug Conjugates (ADCs). Arpita Velani, Syafiq Kay, Earl F. Albone, David E. Thurston
, 2019
, Pages 117-136
- Cytotoxic Payloads for Antibody–Drug Conjugates, CHAPTER 5 Maytansinoid Payloads for Antibody–Drug Conjugates (ADCs). Wayne C. Widdison
, 2019
, Pages 100-116
- Cytotoxic Payloads for Antibody–Drug Conjugates, CHAPTER 2 Design Factors Important for Antibody–Drug Conjugate (ADC) Payloads. John M. Lambert
, 2019
, Pages 31-56
- Biotherapeutics: Recent Developments using Chemical and Molecular Biology, CHAPTER 6 Recent Advances in Antibody–Drug Conjugates. Edmund I. Graziani, L. Nathan Tumey
, 2013
, Pages 145-175
- Privileged Scaffolds in Medicinal Chemistry: Design, Synthesis, Evaluation, Chapter 13 Natural Product Scaffolds of Value in Medicinal Chemistry. David J. Newman, Gordon M. Cragg
, 2016
, Pages 348-378
- Macrocycles in Drug Discovery, CHAPTER 1 Bioactive Macrocycles from Nature. David J. Newman, Gordon M. Cragg
, 2015
, Pages 1-36
- Cytotoxic Payloads for Antibody–Drug Conjugates, CHAPTER 19 Amatoxins as RNA Polymerase II Inhibiting Antibody–Drug Conjugate (ADC) Payloads. Andreas Pahl, Christian Lutz, Torsten Hechler
, 2019
, Pages 398-426
- Chemical Linkers in Antibody-Drug Conjugates (ADCs), Chapter 9 The Use of Uniform PEG Compounds in the Design of ADCs. M. W. Giese, R. H. Woodman, G. T. Hermanson, P. D. Davis
, 2022
, Pages 286-376
- General and Synthetic Methods: Volume 5, Strategy and design in synthesis. G. Pattenden, A. P. Johnson
, 1982
, Volume 5
, Pages 387-413